stockrow
Friday 6 November 2026
Export SOLV’s income statement to Excel — free account
Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.
- Revenue
- −7.01%
- EPS
- −101.0%
- Free cash flow
- +561.9%
- Total debt
- −90.1%
Quarter to September 2026, against a year earlier
86.56
2.79
−3.12%
Follow SOLV
Alert me
Solventum Corporation (SOLV) Gross margin
Solventum Corporation's gross margin over the twelve months to 30 September 2026 was 0.00%, down 53.5 percentage points from fiscal 2025 (53.5%). That is below the Medical Instruments & Supplies industry median of 53.6% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 53.5% | (2.18) |
| FY2024 | 55.7% | (1.60) |
| FY2023 | 57.3% | (0.50) |
| FY2022 | 57.8% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 0.00% | (58.22) |
| Jun 2026 | 58.2% | 3.61 |
| Mar 2026 | 54.6% | 3.21 |
| Dec 2025 | 51.4% | (2.75) |
| 11 more quarters | Free account |
Gross margin against peers
| Company | Gross margin |
|---|---|
| ALGN Align Technology, Inc. compare | 69.1% |
| COO The Cooper Companies, Inc. compare | 65.9% |
| BLCO Bausch + Lomb Corporation compare | 62.6% |
| RGEN Repligen Corporation compare | 53.5% |
| WST West Pharmaceutical Services, Inc. compare | 37.6% |
| ATR AptarGroup, Inc. compare | 35.8% |
| AVTR Avantor, Inc. compare | 31.6% |
| BAX Baxter International Inc. compare | 30.1% |
| SOLV Solventum Corporation | 0.00% |
| Medical Instruments & Supplies industry median | 53.6% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement